tetano
Editor, Senior Moderator
PLoS One
. 2024 Jun 25;19(6):e0303019.
doi: 10.1371/journal.pone.0303019. eCollection 2024. The role of veterinary diagnostic laboratories during COVID-19 response in the United States
Nia Clements[SUP] 1 [/SUP], Diego G Diel[SUP] 2 [/SUP], François Elvinger[SUP] 2 [/SUP], Gary Koretzky[SUP] 3 4 [/SUP], Julie Siler[SUP] 1 [/SUP], Lorin D Warnick[SUP] 2 [/SUP]
Affiliations
Robust testing capacity was necessary for public health agencies to respond to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the coronavirus disease 19 (COVID-19) pandemic. As the nation faced the need for robust testing capacity, it became necessary to use all possible resources. In many cases, veterinary diagnostic laboratories rose to meet this demand because these facilities routinely perform high throughput diagnostic testing of large animal populations and are typically familiar with pathogens of high pandemic concern. In this study, we evaluated the impact of veterinary diagnostic laboratories in the United States on SARS-CoV-2 testing. Results of surveys, semi-structured interviews, and analysis of publicly available information showed that veterinary diagnostic laboratories had a substantial impact on human health through population-level testing in the COVID-19 response, supporting timely and informed public health interventions. This success was not without significant hurdles, as many participating veterinary diagnostic laboratories experienced restriction in their response due to difficulties obtaining the Clinical Laboratory Improvement Amendments (CLIA) certification required to conduct human diagnostic testing. Our results point out the importance of reducing hurdles before the next major public health emergency to enhance access to testing resources overall and to ultimately improve population health.
. 2024 Jun 25;19(6):e0303019.
doi: 10.1371/journal.pone.0303019. eCollection 2024. The role of veterinary diagnostic laboratories during COVID-19 response in the United States
Nia Clements[SUP] 1 [/SUP], Diego G Diel[SUP] 2 [/SUP], François Elvinger[SUP] 2 [/SUP], Gary Koretzky[SUP] 3 4 [/SUP], Julie Siler[SUP] 1 [/SUP], Lorin D Warnick[SUP] 2 [/SUP]
Affiliations
- PMID: 38917105
- PMCID: PMC11198799
- DOI: 10.1371/journal.pone.0303019
Robust testing capacity was necessary for public health agencies to respond to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during the coronavirus disease 19 (COVID-19) pandemic. As the nation faced the need for robust testing capacity, it became necessary to use all possible resources. In many cases, veterinary diagnostic laboratories rose to meet this demand because these facilities routinely perform high throughput diagnostic testing of large animal populations and are typically familiar with pathogens of high pandemic concern. In this study, we evaluated the impact of veterinary diagnostic laboratories in the United States on SARS-CoV-2 testing. Results of surveys, semi-structured interviews, and analysis of publicly available information showed that veterinary diagnostic laboratories had a substantial impact on human health through population-level testing in the COVID-19 response, supporting timely and informed public health interventions. This success was not without significant hurdles, as many participating veterinary diagnostic laboratories experienced restriction in their response due to difficulties obtaining the Clinical Laboratory Improvement Amendments (CLIA) certification required to conduct human diagnostic testing. Our results point out the importance of reducing hurdles before the next major public health emergency to enhance access to testing resources overall and to ultimately improve population health.